Aimovig and Gastrointestinal perforation - a phase IV clinical study of FDA data
Gastrointestinal perforation is found among people who take Aimovig, especially for people who are female, 40-49 old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Aimovig and have Gastrointestinal perforation. It is created by eHealthMe based on reports of 38,155 people who have side effects when taking Aimovig from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
38,155 people reported to have side effects when taking Aimovig.
Among them, 7 people (0.02%) have Gastrointestinal perforation.
What is Aimovig?
Aimovig has active ingredients of erenumab-aooe. eHealthMe is studying from 38,218 Aimovig users for its effectiveness, alternative drugs and more.
What is Gastrointestinal perforation?
Gastrointestinal perforation (hole in the digestive tract) is found to be associated with 1,858 drugs and 1,320 conditions by eHealthMe.
Number of Aimovig and Gastrointestinal perforation reports submitted per year:
Time on Aimovig when people have Gastrointestinal perforation *:
- < 1 month: 100 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
Gender of people who have Gastrointestinal perforation when taking Aimovig *:
- female: 75 %
- male: 25 %
Age of people who have Gastrointestinal perforation when taking Aimovig *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 100 %
- 50-59: 0.0 %
- 60+: 0.0 %
Common drugs people take besides Aimovig *:
- Zyrtec: 1 person, 14.29%
- Zofran: 1 person, 14.29%
- Xulane: 1 person, 14.29%
- Xarelto: 1 person, 14.29%
- Voltaren: 1 person, 14.29%
- Vitamin D: 1 person, 14.29%
- Singulair: 1 person, 14.29%
- Hydrocodone: 1 person, 14.29%
- Humira: 1 person, 14.29%
- Flonase: 1 person, 14.29%
Common side effects people have besides Gastrointestinal perforation *:
- Intestinal Obstruction: 4 people, 57.14%
- Constipation: 3 people, 42.86%
- Stress And Anxiety: 1 person, 14.29%
- Gastroparesis Postoperative (delayed emptying of food from the stomach after surgery): 1 person, 14.29%
- Appendix Disorder: 1 person, 14.29%
- Arthritis (form of joint disorder that involves inflammation of one or more joints): 1 person, 14.29%
- Asthma: 1 person, 14.29%
- Depression: 1 person, 14.29%
- Disability: 1 person, 14.29%
- Fibromyalgia (a long-term condition which causes pain all over the body): 1 person, 14.29%
Common conditions people have *:
- Migraine (headache): 3 people, 42.86%
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 14.29%
- Embolism (obstruction of an artery, typically by a clot of blood or an air bubble): 1 person, 14.29%
* Approximation only. Some reports may have incomplete information.
Do you take Aimovig and have Gastrointestinal perforation?Check whether Gastrointestinal perforation is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Gastrointestinal perforation and when was it recovered:
Expand to all the drugs that have ingredients of erenumab-aooe:
Alternative drugs to, pros and cons of Aimovig:
- Aimovig (38,218 reports)
Common Aimovig side effects:
- Migraine (headache): 3,203 reports
- Drug ineffective: 3,055 reports
- Constipation: 2,982 reports
- Headache (pain in head): 1,940 reports
- Fatigue (feeling of tiredness): 1,375 reports
- Hair loss: 1,199 reports
- Dizziness: 1,106 reports
Browse all side effects of Aimovig:a b c d e f g h i j k l m n o p q r s t u v w x y z
Gastrointestinal perforation treatments and more:
- Gastrointestinal perforation (15,900 reports)
COVID vaccines that are related to Gastrointestinal perforation:
- Gastrointestinal perforation in Moderna COVID Vaccine
- Gastrointestinal perforation in Pfizer BioNTech Covid Vaccine
- Gastrointestinal perforation in Johnson and Johnson Covid Vaccine
Common drugs associated with Gastrointestinal perforation:
- Humira: 1,528 reports
- Avastin: 1,385 reports
- Prednisone: 1,050 reports
- Fluorouracil: 797 reports
- Methotrexate: 712 reports
- Oxaliplatin: 686 reports
- Prednisolone: 592 reports
- Carboplatin: 532 reports
- Paclitaxel: 501 reports
- Omeprazole: 445 reports
All the drugs that are associated with Gastrointestinal perforation:
- Gastrointestinal perforation (1,858 drugs)
Common conditions associated with Gastrointestinal perforation:
- Crohn's disease: 1,613 reports
- Rheumatoid arthritis: 1,083 reports
- High blood pressure: 567 reports
- Colon cancer: 484 reports
- Pain: 477 reports
- Lung cancer - non-small cell: 342 reports
All the conditions that are associated with Gastrointestinal perforation:
- Gastrointestinal perforation (1,320 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on erenumab-aooe (the active ingredients of Aimovig) and Aimovig (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Flonase and Oedema Mouth - 11 seconds ago
- Acetylcysteine and Spiriva drug interaction - 13 seconds ago
- Erwinaze and Pulmonary Embolism - 20 seconds ago
- Atrovent and Multi-Organ Failure - 21 seconds ago
- Weight Increased and drugs of ingredients of dofetilide - 27 seconds ago
- Ultracet and High Blood Cholesterol - 29 seconds ago
- Drisdol and Nasal Congestion - 34 seconds ago
- Fish Oil and Punctate Keratitis - 45 seconds ago
- Gleevec and Lodine drug interaction - 46 seconds ago
- Testosterone Cypionate and Weakness - 48 seconds ago